- Home
- ISPC vs EDVA Comparison
ISPC vs EDVA Comparison
Compare ISPC & EDVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ISPC | EDVA |
|---|---|---|
| Founded | 2009 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Precision Instruments | Beverages (Production/Distribution) |
| Sector | Health Care | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.2M | 2.0M |
| IPO Year | 2020 | 2012 |
Fundamental Metrics
Financial Performance| Metric | ISPC | EDVA |
|---|---|---|
| Price | $0.81 | $0.19 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 94.4K | ★ 451.8K |
| Earning Date | 11-20-2026 | 11-28-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 87.03 | 32.30 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $1,928,998.00 | $73,066.00 |
| Revenue This Year | $638.10 | $24,377.87 |
| Revenue Next Year | $17.50 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.75 | $0.13 |
| 52 Week High | $115.00 | $0.33 |
Technical Indicators
Market Signals| Indicator | ISPC | EDVA |
|---|---|---|
| Relative Strength Index (RSI) | 32.46 | 55.27 |
| Support Level | $0.75 | $0.17 |
| Resistance Level | $1.15 | $0.31 |
| Average True Range (ATR) | 0.09 | 0.01 |
| MACD | 0.01 | 0.01 |
| Stochastic Oscillator | 23.89 | 95.45 |
Price Performance
Historical ComparisonAbout ISPC iSpecimen Inc.
iSpecimen Inc is a technology-driven company focused on connecting life science researchers who need human biofluids, solid tissues, and hematopoietic stem and immune cells for their research with the available biospecimens. The company generates revenue by procuring various specimens from hospitals, laboratories, and other supply sites. Geographically, it has a presence in the Americas, Europe, the Middle East, Africa, and the Asia Pacific, with the majority coming from the Americas. The Company has one reportable segment: biospecimens.
About EDVA Endovia Health Sciences Inc. Common Stock
Endovia Health Sciences Inc is building a diversified cannabinoid health sciences platform through pharmaceutical innovation, strategic partnerships and disciplined execution. Endovia acquires, develops and commercializes differentiated cannabinoid health technologies across pharmaceutical, veterinary and consumer wellness markets. Endovia's product begins with CannEpil, a cannabinoid pharmaceutical asset, and extends into veterinary development and consumer wellness as the pipeline expands.